Darenzepine
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Product Specifications
CAS Number
84629-61-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
MAChR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Darenzepine.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC=C1/2)C3=CC=CC=C3C2=C/C(N4CCN(C)CC4)=O
Molecular Formula
C21H21N3O2
Molecular Weight
347.41
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Eric Elenko, et al. Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation. US 20170095465 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB0671-100 1x 100 µL
Hepatocyte Specific (OCH1E5), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
